Claris Ventures is a venture capital operator based in Italy specialized in early stage investments in companies active in the development of new drugs with high potential. Established in 2019, Claris Ventures is the first operator in Italy specialized in investments in biotech startups close to clinical development.
The objective of Claris Ventures is to identify and support innovations in the pharmaceutical field, investing in new companies that develop potential drugs that can revolutionize the current treatment scenario in indications with limited therapeutic alternatives.
We’re a young firm building a new model for venture investing. Because we’re not working off a template, every investment professional has the chance to make a meaningful contribution. This role is not just about keeping the trains running on time, but helping us continue to build a top-tier venture capital firm. We put a premium on independence, candor, and transparency. We believe in holding people accountable and letting them succeed on their merits.
We are based in Turin and we typically make initial investments at late preclinical stage, walking our portfolio companies through Phase I/II clinical development.
